Location: Oxford Science Park (Hybrid – 2–3 days on site)
At Oxford Nanopore Technologies, we are redefining what’s possible in molecular sensing. Our pioneering nanopore-based technology is transforming scientific discovery and healthcare by enabling real-time, accessible DNA and RNA sequencing across research, clinical, and applied markets globally. As a fast-growing, innovative organisation with an international footprint, we are building scalable finance capabilities to support the next stage of our growth journey.
We are seeking an experienced Accounts Receivable Manager to lead and transform our global Accounts Receivable and Credit Control function.
This role will drive measurable improvements in cash collection, credit risk management, and DSO reduction, while building a best-in-class Order-to-Cash function across people, process, systems, and automation/AI.
You will lead a team of AR specialists and partner closely with Sales, Customer Service, Treasury, Group Reporting, and IT.
Key Responsibilities- Own the AR strategy and Order-to-Cash roadmap
- Lead and develop the AR and Credit Control team
- Drive DSO reduction and cash collection performance
- Establish robust credit risk governance and policies
- Analyse AR data to identify risks and resolve issues
- Own AR systems (Dynamics 365) including workflows and controls
- Drive adoption of automation, e-invoicing, and AI solutions
- Lead continuous improvement initiatives across Order-to-Cash
- Support IFRS 9 provisioning and bad debt management
- Partner cross-functionally to improve billing accuracy and collections
- Deliver clear reporting on AR performance and risks
- Contribute to wider Finance transformation initiatives
- Extensive experience leading AR / Credit Control globally
- Strong track record in improving collections and reducing DSO
- Deep understanding of Order-to-Cash and credit risk
- Experience driving transformation (process, systems, policy)
- Strong stakeholder management and influencing skills
- Data-driven with a KPI-focused mindset
- ERP experience (Dynamics 365 preferred)
- Desirable AI capability: Demonstrated experience piloting or implementing AI-enabled solutions (e.g. Microsoft 365 Copilot, Power Automate) to enhance Order-to-Cash processes (credit control, collections) and drive measurable efficiency gains
- Opportunity to transform a critical global finance function
- High-impact role with measurable business outcomes
- Fast-growing, innovative, and purpose-driven environment
- Exposure to cutting-edge finance systems and AI adoption
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability, or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-LH1
#LI-hybrid
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Oxford Nanopore Technologies Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Oxford Nanopore Technologies and has not been reviewed or approved by Oxford Nanopore Technologies.
-
Fair & Transparent Compensation — Pay is considered good to above average across many roles, with employer-provided ranges visible for several U.S. commercial and applications positions and company materials emphasizing market‑competitive base pay. Commercial and some senior technical posts, particularly in the U.S., are positioned as competitive and often paired with strong variable components.
-
Equity Value & Accessibility — All‑employee share plans in the UK and a U.S. employee stock purchase plan indicate broad access to equity as part of total reward. Company communications highlight attractive bonus and share plans that add meaningful upside beyond base pay.
-
Healthcare Strength — U.S. roles indicate strong health insurance and core protections, while official materials and country overviews reference private medical coverage and wellbeing support. These elements position the health package as a notable strength alongside cash compensation.
Oxford Nanopore Technologies Insights
Similar Jobs
What We Do
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
